Pramodini Medicare IPO
smelistedAbout the company
Pramodini Medicare was incorporated in 2000 and is an integrated diagnostic service provider offering technology-enabled services across radiology, clinical laboratory and nuclear medicine. The company provides diagnostic services to public hospitals, private hospitals, government public sector undertakings (PSUs), medical colleges and individual patients across Tier I, II and III cities in India. The company’s service portfolio includes MRI, CT scans, X-rays, ultrasound with colour Doppler, mammography, DEXA scans, interventional radiology, pathology, microbiology, immunology, biochemistry, PET-CT, SPECT and nuclear therapy. The company operates through four business models; Public-Private Partnerships (PPP), Private-Private Partnerships, Strategic Partnerships with Government PSUs and standalone diagnostic centres, and also provides 24×7 teleradiology services from Vijayawada. As of the RHP filing date, it operated 16 diagnostic centres across 14 cities in seven states, supported by a processing laboratory in Vijayawada. Its diagnostic infrastructure includes 8 CT scanners, 7 MRI systems, 20 X-ray machines, 15 ultrasound systems, 2 mammography units, 2 DEXA scanners and 1 PET-CT system. Radiology services contributed the largest share of revenue from operations at 97.05% in FY26, followed by clinical laboratory services at 2.37% and nuclear medicine at 0.58%. Revenue from Public-Private Partnership centres accounted for 54.19% of FY26 revenue, while government customers (B2G) contributed 61.46% of revenue from operations. Andhra Pradesh was the largest geographical market, contributing 61.90% of FY26 revenue, followed by Karnataka at 20.82%. During FY26, the company conducted 4.74 lakh diagnostic tests, approximately doubling from the previous year.
GMP trend (Grey Market Premium by date)
| Date | GMP (₹) | Est. Listing | Change |
|---|---|---|---|
| 13 Aug | ₹0 | ₹118 | 0 |
| 12 Aug | ₹0 | ₹118 | 0 |
| 11 Aug | ₹0 | ₹118 | 0 |
| 10 Aug | ₹0 | ₹118 | 0 |
| 09 Aug | ₹0 | ₹118 | 0 |
| 08 Aug | ₹0 | ₹118 | 0 |
| 07 Aug | ₹0 | ₹118 | 0 |
| 06 Aug | ₹0 | ₹118 | 0 |
Strengths
- Diversified diagnostic services portfolio across radiology, pathology and nuclear medicine .
- Strategic presence across multiple states and cities in India.
- Asset-light business model supported by PPP and partnership arrangements .
- Strong technical capabilities backed by robust IT infrastructure.
- Experienced management team with significant healthcare industry expertise.
- Strong recent financial performance, with FY26 revenue and profit showing substantial growth.
Risks
- Significant dependence on government authorities through Public-Private Partnership (PPP) arrangements for revenue.
- High concentration in radiology services exposes the company to segment-specific risks.
- Changes or termination of government contracts could adversely affect revenue and profitability.
- Diagnostic operations depend on expensive medical equipment, making maintenance and technology upgrades important.
- Expansion into new locations may involve execution risks and could take time to generate expected returns.
- As an SME IPO , the stock may face relatively higher liquidity and price-volatility risks after listing.
Financial performance (₹ Cr)
Subscription breakup (final, times)
IPO Roadmap / Timeline
IPO Opens
Completed12 Aug 2026Bidding starts for all investor categories
IPO Closes
Completed14 Aug 2026Last day to place your bid
Basis of Allotment
Completed17 Aug 2026Share allotment finalised
Refund Initiation
Completed18 Aug 2026Refunds credited for non-allottees
Credit to Demat
Completed18 Aug 2026Allotted shares credited to demat account
Listing on Exchange
Completed19 Aug 2026Shares list on NSE / BSE
Post-close dates are indicative as per SEBI T+3 listing framework and may change per registrar updates.
Lot size & minimum investment
| Investor Type | Min Lots | Min Shares | Min Amount | Max Lots | Max Amount | Notes |
|---|---|---|---|---|---|---|
| Retail / Individual | 1 | 1200 | ₹141,600 | 1 | ₹141,600 | 1 lot only |
| HNI | 2 | 2400 | ₹283,200 | 2 | ₹283,200 | Min 2 lots |
Shares reserved per category & allotment probability
| Category | Reservation | Shares Offered | Amount (₹ Cr) | Shares Bid | Subscribed | Allotment % |
|---|---|---|---|---|---|---|
| QIB | 50% | 3,026,316 | 34.5 | 5,477,632 | 1.81x | 55.2% |
| NII | 15% | 907,895 | 10.35 | 617,369 | 0.68x | 100% |
| Retail | 35% | 2,118,421 | 24.15 | 826,184 | 0.39x | 100% |
Retail is a lottery-based allotment when oversubscribed; QIB/NII get pro-rata. Probability ≈ 1 / subscription times (100% if under-subscribed).
